Inventor · disambiguated record
Jay Fine
Also filed as: FINE JAY · FINE JAY S
6 granted patents·10 pending applications·109 citations·filing 1995–2024
83Inventor score
Files withSCHERING CORP7BOEHRINGER INGELHEIM INT5FINE JAY S1HOFFMANN LA ROCHE1PHARMACOPEIA DRUG DISCOVERY1
Top patents by PatentIndex Score
16 records- 0194US7132445B23,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligandsPHARMACOPEIA DRUG DISCOVERY·Filed 2003·Granted Nov 7, 2006·58 cites·82 claims
- 0279US7960433B2Treatment of chemokine mediated diseasesSCHERING CORP·Filed 2007·Granted Jun 14, 2011·4 cites·11 claims
- 0369US2024392019A1Anti-il-36r antibodies for the treatment of neutrophilic dermatosesBOEHRINGER INGELHEIM INT·Filed 2024·Application pending·0 cites
- 0466US7560449B2Methods and therapeutic combinations for the treatment of demyelinationSCHERING CORP·Filed 2003·Granted Jul 14, 2009·5 cites·11 claims
- 0566US5866134AMethod for enhancing the antibody response to specific antigens with Interleukin-10SCHERING CORP·Filed 1995·Granted Feb 2, 1999·30 cites·19 claims
- 0665US5939431ANaphthyridines which affect IL-4 and G-CSFSCHERING CORP·Filed 1997·Granted Aug 17, 1999·12 cites·16 claims
- 0764US12098207B2Anti-IL-36R antibodies for the treatment of pyoderma gangrenosumBOEHRINGER INGELHEIM INT·Filed 2021·Granted Sep 24, 2024·0 cites·8 claims
- 0854US2023049147A1Anti-il-36r antibodies for the treatment of a fibrotic conditionBOEHRINGER INGELHEIM INT·Filed 2022·Application pending·0 cites
- 0953US2007248594A1Cxcr1 and cxcr2 chemokine antagonistsSCHERING CORP·Filed 2007·Application pending·0 cites
- 1053US2011213029A13,4-Di-Substituted Cyclobutene-1,2-Diones as CXC-Chemokine Receptor LigandsSCHERING CORP·Filed 2011·Application pending·0 cites
- 1151US2023193269A1Oligonucleotides for splice modulation of card9BOEHRINGER INGELHEIM INT·Filed 2020·Application pending·0 cites
- 1249US2004186142A1Thiadiazoledioxides and thiadiazoleoxides as CXC- and CC- chemokine receptor ligandsSCHERING CORP PHARMACOPEIA INC·Filed 2003·Application pending·0 cites
- 1349US2022010022A1Anti-il-36r antibodies for the treatment of atopic dermatitisBOEHRINGER INGELHEIM INT·Filed 2021·Application pending·0 cites
- 1449US2008166318A1Methods and therapeutic combinations for the treatment of demyelinationFINE JAY S·Filed 2008·Application pending·0 cites
- 1547US2004053953A1Treatment of chemokine mediated diseasesSCHERING CORP·Filed 2003·Application pending·0 cites
- 1645US2022042011A1Antisense oligonucleotides targeting card9HOFFMANN LA ROCHE·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jay Fine files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →